Clinical research builds on the advances of basic and translational research to improve health and reduce the impact of disease and injury. This form of research is typically conducted with human subjects over the period of years. The Duke Department of Neurology is conducting clinical research in several areas, from multiple sclerosis, traumatic brain injury, to nerve pain caused by chemotherapy. We also conduct clinical trials in all major areas of neurology.
The Duke Department of Neurology is involved with more than 100 ongoing or recently completed clinical trials, including the following which are actively seeking recruits:
ALS (Amyotrophic Lateral Sclerosis):
- ALS Reversals - Lunasin Regimen
- Ventilatory Investigation of Tirasemtiv and Assessment of Longitudinal Indices After Treatment for a Year
Gliobastoma (Brain Tumor)
- Twelve-week Study of the Safety and Efficacy of JZP-110 in the Treatment of Excessive Sleepiness in Narcolepsy
- A Study of Weekly Subcutaneous Injections of SER-214 in Subjects With Parkinson's Disease (PD), to Determine the Safety, Tolerability and Pharmacokinetic (PK) Profile of SER-214
Visit Clinicaltrials.gov for more information about Clinical Trials at Duke.